multi-cancer early detection
Researchers Stress Specificity of Grail Multi-Cancer Detection Test in Response to Study Criticism
Premium
The authors of a commentary said they view recent study results as informative, though limited, regarding the test's performance in prostate cancer.
Investigators are trialing methods to boost sensitivity for certain cancers, and assessing measures of how tests may impact clinical care in certain screening subpopulations.
Hackensack Meridien Health Launches Cancer Risk, Early Detection Program; Eyes Multi-Cancer Testing
Premium
Patients will be offered germline genetic testing after an assessment that includes genetic, lifestyle, and other clinical risk factor analysis.
Exact Sciences Enrolls First Patient in Multi-Cancer Early Detection Study
Participants enrolled in the registry study will receive three years of MCED testing and two years of follow-on data collection.
Grail to Cut Headcount by 30 Percent in Restructuring, Reports 43 Percent Q2 Revenue Rise
Reporting its financial results as a separate company for the first time since its spinoff from Illumina, Grail said the restructuring will save it $27 million this year.